Bayer Turns to U.S. Appeals Courts as Roundup Legal Challenges Mount
Leverkusen, Germany – As Bayer AG grapples with a series of U.S. legal challenges concerning its Roundup weed killer, the German pharmaceutical and life sciences giant is placing its confidence in the ability of the U.S. appeals courts to lead it through a costly litigation quagmire. Bayer, which acquired Monsanto in 2018, inherited thousands of legal claims alleging that Roundup causes cancer – a claim that the company contests. Bayer’s strategy hinges on a pivotal legal question: whether federal regulatory approvals should shield it from state-law failure-to-warn claims. The company points to the U.S. Environmental … Read more